Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study

BACKGROUND/OBJECTIVE: Treatment of subjects with non-alcoholic fatty liver disease (NAFLD) with omega-3 polyunsaturated fatty acids (FAs) suggests high levels of docosahexaenoic acid (DHA) tissue enrichment decrease liver fat content. We assessed whether changes in erythrocyte DHA enrichment (as a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodson, L, Bhatia, L, Scorletti, E, Smith, D E, Jackson, N C, Shojaee-Moradie, F, Umpleby, M, Calder, P C, Byrne, C D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474320/
https://www.ncbi.nlm.nih.gov/pubmed/28294174
http://dx.doi.org/10.1038/ejcn.2017.9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474320/
https://www.ncbi.nlm.nih.gov/pubmed/28294174
http://dx.doi.org/10.1038/ejcn.2017.9

Ejemplares similares